Atomoxetine and Oxybutynin in Obstructive Sleep Apnea

NCT02908529 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea (OSA)

Interventions

DRUG: Combination product of Atomoxetine and Oxybutynin
DRUG: Placebo, 2 tablets

Sponsor

Brigham and Women's Hospital